BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

932 related articles for article (PubMed ID: 22683710)

  • 21. Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma.
    da Costa WH; da Cunha IW; Fares AF; Bezerra SM; Shultz L; Clavijo DA; da Silva DV; Netto GJ; Guimaraes GC; Cassio Zequi S
    Urol Oncol; 2018 May; 36(5):243.e1-243.e8. PubMed ID: 29426696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
    Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
    Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetics of clear-cell renal cell carcinoma.
    Brugarolas J
    J Clin Oncol; 2014 Jun; 32(18):1968-76. PubMed ID: 24821879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline BAP1 mutations predispose to renal cell carcinomas.
    Popova T; Hebert L; Jacquemin V; Gad S; Caux-Moncoutier V; Dubois-d'Enghien C; Richaudeau B; Renaudin X; Sellers J; Nicolas A; Sastre-Garau X; Desjardins L; Gyapay G; Raynal V; Sinilnikova OM; Andrieu N; Manié E; de Pauw A; Gesta P; Bonadona V; Maugard CM; Penet C; Avril MF; Barillot E; Cabaret O; Delattre O; Richard S; Caron O; Benfodda M; Hu HH; Soufir N; Bressac-de Paillerets B; Stoppa-Lyonnet D; Stern MH
    Am J Hum Genet; 2013 Jun; 92(6):974-80. PubMed ID: 23684012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
    Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R; Bottaro DP; Choueiri TK; Gibbs RA; Godwin AK; Haake S; Hakimi AA; Henske EP; Hsieh JJ; Ho TH; Kanchi RS; Krishnan B; Kwiatkowski DJ; Liu W; Merino MJ; Mills GB; Myers J; Nickerson ML; Reuter VE; Schmidt LS; Shelley CS; Shen H; Shuch B; Signoretti S; Srinivasan R; Tamboli P; Thomas G; Vincent BG; Vocke CD; Wheeler DA; Yang L; Kim WY; Robertson AG; ; Spellman PT; Rathmell WK; Linehan WM
    Cell Rep; 2018 Apr; 23(1):313-326.e5. PubMed ID: 29617669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.
    Yu H; Mashtalir N; Daou S; Hammond-Martel I; Ross J; Sui G; Hart GW; Rauscher FJ; Drobetsky E; Milot E; Shi Y; Affar el B
    Mol Cell Biol; 2010 Nov; 30(21):5071-85. PubMed ID: 20805357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of BAP1 protein expression in the first metastatic site predicts prognosis in patients with clear cell renal cell carcinoma.
    Miura Y; Inoshita N; Ikeda M; Miyama Y; Oki R; Oka S; Kondoh C; Ozaki Y; Tanabe Y; Kurosawa K; Urakami S; Kohno T; Okaneya T; Takano T
    Urol Oncol; 2017 Jun; 35(6):386-391. PubMed ID: 28284891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization of MCRS1 by BAP1 prevents chromosome instability in renal cell carcinoma.
    Peng J; Ma J; Li W; Mo R; Zhang P; Gao K; Jin X; Xiao J; Wang C; Fan J
    Cancer Lett; 2015 Dec; 369(1):167-74. PubMed ID: 26300492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling Renal Cell Carcinoma in Mice:
    Gu YF; Cohn S; Christie A; McKenzie T; Wolff N; Do QN; Madhuranthakam AJ; Pedrosa I; Wang T; Dey A; Busslinger M; Xie XJ; Hammer RE; McKay RM; Kapur P; Brugarolas J
    Cancer Discov; 2017 Aug; 7(8):900-917. PubMed ID: 28473526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linking Binary Gene Relationships to Drivers of Renal Cell Carcinoma Reveals Convergent Function in Alternate Tumor Progression Paths.
    Poehlman WL; Hsieh JJ; Feltus FA
    Sci Rep; 2019 Feb; 9(1):2899. PubMed ID: 30814637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.
    Bi M; Zhao S; Said JW; Merino MJ; Adeniran AJ; Xie Z; Nawaf CB; Choi J; Belldegrun AS; Pantuck AJ; Kluger HM; Bilgüvar K; Lifton RP; Shuch B
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2170-5. PubMed ID: 26864202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma.
    Kapur P; Christie A; Raman JD; Then MT; Nuhn P; Buchner A; Bastian P; Seitz C; Shariat SF; Bensalah K; Rioux-Leclercq N; Xie XJ; Lotan Y; Margulis V; Brugarolas J
    J Urol; 2014 Mar; 191(3):603-10. PubMed ID: 24076305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
    Wang SS; Gu YF; Wolff N; Stefanius K; Christie A; Dey A; Hammer RE; Xie XJ; Rakheja D; Pedrosa I; Carroll T; McKay RM; Kapur P; Brugarolas J
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16538-43. PubMed ID: 25359211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development.
    Duns G; Hofstra RM; Sietzema JG; Hollema H; van Duivenbode I; Kuik A; Giezen C; Jan O; Bergsma JJ; Bijnen H; van der Vlies P; van den Berg E; Kok K
    Hum Mutat; 2012 Jul; 33(7):1059-62. PubMed ID: 22461374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC).
    Ricketts CJ; Linehan WM
    PLoS One; 2015; 10(10):e0140257. PubMed ID: 26484545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An emerging model for BAP1's role in regulating cell cycle progression.
    Eletr ZM; Wilkinson KD
    Cell Biochem Biophys; 2011 Jun; 60(1-2):3-11. PubMed ID: 21484256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer.
    Liao L; Testa JR; Yang H
    Cancer Genet; 2015 May; 208(5):206-14. PubMed ID: 25873528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.
    Machida YJ; Machida Y; Vashisht AA; Wohlschlegel JA; Dutta A
    J Biol Chem; 2009 Dec; 284(49):34179-88. PubMed ID: 19815555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma.
    Joseph RW; Kapur P; Serie DJ; Eckel-Passow JE; Parasramka M; Ho T; Cheville JC; Frenkel E; Rakheja D; Brugarolas J; Parker A
    Cancer; 2014 Apr; 120(7):1059-67. PubMed ID: 24382589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
    Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
    Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.